Is your compound actually therapeutic?
Taylor-Stocke et al. Breast 2019 Ishii et al. Nature Scientific Reports 2017 Speak to our experts Learn how CETSA® can enable your project by talking to one of our Drug Discovery…
Taylor-Stocke et al. Breast 2019 Ishii et al. Nature Scientific Reports 2017 Speak to our experts Learn how CETSA® can enable your project by talking to one of our Drug Discovery…
Martinez Molina et al. Science 2013 Soucek et al. Nat Rev Cancer 2017 Sexl et al. Int J Cancer 2020 Speak to our experts Learn how CETSA® can enable your project by talking to one of our Drug Discovery…
Martinez Molina et al. Science 2013 Jafari et al.Nature Protocols 2014 Ishii et al. Nature Scientific Reports 2017 Speak to our experts Learn how CETSA® can enable your project by talking to one of our Drug Discovery…
Savitski et al. Science 2014 Hendricks et al. ACS Chem Bio Speak to our experts Learn how CETSA® can enable your project by talking to one of our Drug Discovery…
How can I confirm if my hit is on target? Download our CETSA® Navigate HT application note…
Chernobrovkin, Alexey L. et al. SLAS discovery : advancing life sciences R & D vol. 26,4 (2021): 534-546. doi:10.1177/2472555220984372 Morgan, Paul et al. Drug discovery today vol. 17,9-10 (2012): 419-24. doi:10.1016/j. drudis.2011.12.020 Bunnage, Mark E et al. Nature chemical…
CETSA® Explore for hit evaluation and target deconvolution Recent years have seen a resurgence in phenotypic drug discovery owing to its potential for delivering first-in-class treatments for diseases with unmet clinical needs1. However, one of the major challenges to…